Stockscreener 앱 받기
2.24
3.24%
-0.075
시간 외 거래:
2.24
전일 마감가:
$2.315
열려 있는:
$2.29
하루 거래량:
312.56K
Relative Volume:
0.72
시가총액:
$47.38M
수익:
-
순이익/손실:
$-16.51M
주가수익비율:
-1.224
EPS:
-1.83
순현금흐름:
$-15.68M
1주 성능:
-12.16%
1개월 성능:
+15.46%
6개월 성능:
-43.43%
1년 성능:
+0.00%
1일 변동 폭
$2.18
$2.3599
1주일 범위
$2.18
$2.6999
52주 변동 폭
$1.7901
$8.94
Medicus Pharma Ltd Stock (MDCX) Company Profile
명칭
Medicus Pharma Ltd
전화
610-540-7515
주소
300 CONSHOHOCKEN STATE RD., W. CONSHOHOCKEN
MDCX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
MDCX
Medicus Pharma Ltd
|
2.24 | 47.38M | 0 | -16.51M | -15.68M | -1.83 |
|
LLY
Lilly Eli Co
|
825.42 | 684.00B | 53.26B | 13.80B | -50.20M | 15.30 |
|
JNJ
Johnson Johnson
|
186.05 | 446.55B | 90.62B | 22.66B | 18.18B | 9.35 |
|
ABBV
Abbvie Inc
|
244.38 | 409.03B | 58.33B | 3.73B | 18.24B | 2.10 |
|
NVS
Novartis Ag Adr
|
131.72 | 248.25B | 53.40B | 13.68B | 16.89B | 6.9231 |
|
MRK
Merck Co Inc
|
90.13 | 209.64B | 63.43B | 16.42B | 14.72B | 6.49 |
Medicus Pharma Ltd 주식(MDCX)의 최신 뉴스
What Wall Street predicts for Medicus Pharma Ltd. stock price2025 Analyst Calls & AI Driven Price Predictions - newser.com
Using AI based signals to follow Medicus Pharma Ltd.Market Growth Report & Long-Term Capital Growth Ideas - newser.com
Custom strategy builders for tracking Medicus Pharma Ltd. Equity Warrant2025 Geopolitical Influence & Advanced Technical Analysis Signals - newser.com
Trend analysis for Medicus Pharma Ltd. Equity Warrant this weekQuarterly Earnings Report & Fast Exit/Entry Strategy Plans - newser.com
Is Medicus Pharma Ltd. Equity Warrant stock affected by interest rate hikesPortfolio Profit Report & Smart Allocation Stock Tips - newser.com
Is Medicus Pharma Ltd. (N460) stock a momentum leaderInflation Watch & Free Expert Verified Stock Movement Alerts - newser.com
Is Medicus Pharma Ltd. Equity Warrant still worth holding after the dipJuly 2025 Earnings & Real-Time Sentiment Analysis - newser.com
Smart tools for monitoring Medicus Pharma Ltd. Equity Warrant’s price actionJuly 2025 Opening Moves & Risk Controlled Swing Trade Alerts - newser.com
Why Medicus Pharma Ltd. (N460) stock fits value portfoliosJuly 2025 Pullbacks & Entry Point Strategy Guides - newser.com
Using data filters to optimize entry into Medicus Pharma Ltd.Market Performance Summary & Technical Confirmation Trade Alerts - newser.com
Medicus Pharma Ltd’s Promising Prospects: Innovative BCC Treatment and Strong FDA Support Drive Buy Rating - TipRanks
Relative strength of Medicus Pharma Ltd. Equity Warrant in sector analysis2025 Momentum Check & Daily Price Action Insights - newser.com
Is Medicus Pharma Ltd. Equity Warrant stock entering bullish territoryWeekly Investment Report & Weekly Hot Stock Watchlists - newser.com
Using AI based signals to follow Medicus Pharma Ltd. Equity WarrantRecession Risk & Weekly Chart Analysis and Guides - newser.com
How currency fluctuations impact Medicus Pharma Ltd. Equity Warrant stockPrice Action & Reliable Entry Point Trade Alerts - newser.com
Medicus Pharma gets FDA nod for 505(b)(2) pathway in skin cancer treatment - Investing.com Nigeria
Regression analysis insights on Medicus Pharma Ltd. performance2025 Stock Rankings & Daily Momentum Trading Reports - newser.com
How Medicus Pharma Ltd. (N460) stock performs in easing cyclesEarnings Overview Summary & Fast Momentum Stock Entry Tips - newser.com
Medicus Pharma Ltd. Receives Positive Feedback From the Food and Drug Adminstration (FDA) Type C Meeting Supporting the Development of Skinject - Naples Daily News
Medicus Pharma gets positive FDA feedback on Skinject microneedle therapy for basal cell carcinoma - Proactive financial news
How Medicus Pharma Ltd. (N460) stock reacts to Fed tighteningQuarterly Profit Summary & Reliable Intraday Trade Alerts - newser.com
Medicus Pharma Ltd. Equity Warrant stock outlook for YEAREarnings Risk Report & Verified Trade Idea Suggestions - newser.com
Medicus Pharma Advances Skinject Development with Positive FDA Feedback - TipRanks
Medicus Pharma gets FDA backing to advance skin cancer patch - Proactive financial news
Medicus Pharma announces feedback from FDA Type C Meeting for Skinject - TipRanks
Is Medicus Pharma Ltd. Equity Warrant forming a bottoming baseIndex Update & Fast Entry High Yield Stock Tips - newser.com
$2B Market Opportunity: FDA Supports Medicus Pharma's Novel Skin Cancer Treatment Using Dissolving Microneedles - Stock Titan
Can Tirupati Sarjan Limited Expand Its Margins in a HighRate EnvironmentIndustrial Stocks Review & You’ll Regret Not Buying These Early - earlytimes.in
Is Medicus Pharma Ltd Equity Warrant a good long term investmentDividend Stock Watch & Free Superior Trading Gains - earlytimes.in
Medicus Pharma Ltd. Provides Update on United Arab Emirates (UAE) SKNJCT-004 Phase 2 Clinical Study to Non-Invasively Treat Basal Cell Carcinoma of the Skin (BCC) - Online Athens
Medicus Pharma Ltd Equity Warrant Stock Analysis and ForecastMarket Sentiment Shifts & Small Entry Portfolio - earlytimes.in
How Medicus Pharma Ltd. (N460) stock trades in high volatility2025 Year in Review & Reliable Volume Spike Trade Alerts - newser.com
Medicus Pharma to Present Key Developments at Brookline Capital Markets - MSN
Custom strategy builders for tracking Medicus Pharma Ltd.Weekly Trend Report & AI Forecasted Stock Moves - newser.com
Stonegate Capital Partners Initiates Coverage on Medicus Pharma with $21.13 Valuation Target - citybuzz -
Medicus Pharma Ltd (MDCX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
5.42%
자본화:
|
볼륨(24시간):